ArticleCancer causes & control : CCC2026
Factors associated with cervical cancer screening in the South African demographic and health survey.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCervical cancer is South Africa's second most common cancer among women, yet for complex reasons, Papanicolaou screening uptake remains suboptimal. Only a few studies have explored the interplay between sociodemographic characteristics, women's empowerment, healthcare access, and lifestyle behaviors in influencing screening participation. We examined the associations between cervical cancer screening uptake and sociodemographic, women's empowerment, healthcare access, and risky lifestyle behaviors factors.
methodsCross-sectional analyses of a nationally representative dataset of women (n = 2789) aged 25-49 years were conducted from the 2016 South African Demographic and Health Survey. We used multivariable generalized linear regression models with Poisson distribution to estimate screening uptake (adjusted prevalence) ratios (aPRs, and 95% confidence intervals (95% CI)). We ordered the factors by their attributable fractions (AF), which takes the proportion of uptake per category into account.
resultsBeing tested for HIV (aPR = 1.79; 95% CI:1.40-2.30; AF = 41.7%), population group (being Black) (aPR = 0.75; 95% CI:0.66-0.84; AF = 19.7%), rich (aPR = 1.34, 95% CI:1.08-1.67; AF = 15.9%), and education (aPR = 1.18, 95% CI:1.03-1.36; AF = 8.9%), were the most important determinants of cervical screening uptake in South Africa. Alcohol misuse (aPR = 1.23; 95% CI:1.10-1.38; AF = 6.1%), having health insurance (aPR:1.27; 95% CI:1.12-1.45; AF = 5.5%) and disempowerment (aPR = 1.10; 95% CI:1.00-1.22; AF = 5.5%) were less important drivers of screening uptake.
conclusionsPap smear uptake remains suboptimal, particularly among Black women. There is a need for enhanced awareness and education initiatives as well as novel strategies involving community-based screening programs to encourage the uptake of cervical screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.